🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wei Deng

Guangzhou University of Chinese Medicine

ORCID: 0000-0003-1778-2013

Also affiliated with Peking University, Second Affiliated Hospital of Guangzhou Medical University, Peking University Cancer Hospital, Mianyang Central Hospital, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou Medical University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)”.

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.034
N/A
5.8DataRank · unranked
155 citations

Wei Deng, Michael Frumovitz, Natália Buza, Stefania Bellone, Warner K. Huh +7 more

The presence of an endometrioid component does not alter the clinicopathologic profile or survival of patients with uterine serous cancer: A gynecologic oncology group (GOG/NRG) study of 934 women

Gynecologic Oncology(2021)10.1016/j.ygyno.2020.12.040
N/A
0.941DataRank · unranked
26 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille C. Gunderson, Casey Cosgrove +15 more

Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279

Journal of Clinical Oncology(2024)10.1200/jco.23.02235
N/A
0.637DataRank · unranked
19 citations

Wei Deng, I. Peterson, Robert S. Mannel, J. S. Thompson, Elizabeth Lokich +12 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005
N/A
0.360DataRank · unranked
10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more

Exploring sex-specific clinical features in Chinese patients with Takotsubo syndrome

BMC Cardiovascular Disorders(2025)10.1186/s12872-025-04788-4
N/A
0.104DataRank · unranked
1 citations

Wang Ling-lin, Lingchun Lyu, Zhenhua Shi, Xiaoping Lin, Zhengyang Yu +17 more

Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.001
N/A
0DataRank · unranked
5 citations

Wei Deng, Michael A. Gold, Rajani Rai, Rachel Conrad, Hanke van der Wel +8 more

Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial

Nature Communications(2025)10.1038/s41467-024-55200-2
N/A
0DataRank · unranked
18 citations

Dmitriy Zamarin, Wei Deng, Heather A. Lankes, Giulio Pesci, Hayeon Kim +19 more

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-0226
N/A
0DataRank · unranked
57 citations

Kirsten B. Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu +16 more